Aeterna Zentaris Completes Major Share Consolidation
Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
AEterna Zentaris To Carry Out 1-for-4 Reverse Stock Split On May 3rd, 2024
May 2nd - $AEterna Zentaris(AEZS.US)$ is about to implement a 1-for-4 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from May 3rd, 2024.$AEterna Zentaris(AEZS.U
Aeterna Zentaris Announces Share Consolidation
Aeterna Zentaris Initiates Major Share Consolidation
Aeterna Zentaris Announced That It Has Filed Articles Of Amendment To Effect The Previously Announced Share Consolidation (or Reverse Stock Split) Of Its Issued And Outstanding Common Shares
Aeterna Zentaris Announced That It Has Filed Articles Of Amendment To Effect The Previously Announced Share Consolidation (or Reverse Stock Split) Of Its Issued And Outstanding Common Shares
12 ChatGPT Penny Stock Picks Right Now
Aeterna Zentaris Announces Merger Approval
Ceapro Brief: Parties Anticipate Completing Transaction in Q2 2024, Subject to Obtaining All Required Approvals and Satisfying All Required Conditions
08:02 AM EDT, 03/28/2024 (MT Newswires) -- Ceapro Brief: Parties anticipate completing Transaction in Q2 2024, subject to obtaining all required approvals and satisfying all required conditions
AEterna Zentaris and Ceapro Anticipate Completing the Transaction in the 2Q of 2024 >AEZS
AEterna Zentaris and Ceapro Anticipate Completing the Transaction in the 2Q of 2024 >AEZS
Ceapro Receives Final Court Approval for Merger With Aeterna Zentaris
Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris AEZS
Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris AEZS
Aeterna Zentaris Financials Affirm Compliance
Aeterna Zentaris Completes Trial Enrollment, Plans Merger
Aeterna Zentaris Reports Q4 Results
AEterna Zentaris Q4 2023 GAAP EPS $(1.16) Misses $(0.97) Estimate, Sales $100.000K Down From $2.485M YoY
AEterna Zentaris Q4 2023 GAAP EPS $(1.16) Misses $(0.97) Estimate, Sales $100.000K Down From $2.485M YoY
Aeterna Zentaris Brief: Reporting Q4 Net Loss of US$5.6 Million, or $1.16 Loss per Common Share
08:07 AM EDT, 03/27/2024 (MT Newswires) -- Aeterna Zentaris Brief: Reporting Q4 Net Loss of US$5.6 million, or $1.16 loss per common share
AEterna Zentaris 4Q Loss/Shr $1.16 >AEZS
AEterna Zentaris 4Q Loss/Shr $1.16 >AEZS
Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
TORONTO and EDMONTON, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) ("Aeterna") and Ceapro Inc. (TSXV:CZO, OTCQX:CRPOF) ("Ceapro") are pleased to announce that securityholders of
No Data